Organoclick AB (ORGC) - Net Assets

Latest as of March 2026: Skr18.77 Million SEK ≈ $2.02 Million USD

Based on the latest financial reports, Organoclick AB (ORGC) has net assets worth Skr18.77 Million SEK (≈ $2.02 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr147.69 Million ≈ $15.89 Million USD) and total liabilities (Skr128.92 Million ≈ $13.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ORGC asset base for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr18.77 Million
% of Total Assets	12.71%
Annual Growth Rate	3.36%
5-Year Change	-81.06%
10-Year Change	-50.79%
Growth Volatility	221.71

Organoclick AB - Net Assets Trend (2012–2025)

This chart illustrates how Organoclick AB's net assets have evolved over time, based on quarterly financial data. Check ORGC intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Organoclick AB (2012–2025)

The table below shows the annual net assets of Organoclick AB from 2012 to 2025. For live valuation and market cap data, see Organoclick AB market cap and net worth.

Year	Net Assets	Change
2025-12-31	Skr20.41 Million ≈ $2.20 Million	-46.06%
2024-12-31	Skr37.83 Million ≈ $4.07 Million	-29.16%
2023-12-31	Skr53.41 Million ≈ $5.75 Million	-20.95%
2022-12-31	Skr67.56 Million ≈ $7.27 Million	-37.29%
2021-12-31	Skr107.73 Million ≈ $11.59 Million	+29.88%
2020-12-31	Skr82.94 Million ≈ $8.93 Million	-19.06%
2019-12-31	Skr102.47 Million ≈ $11.03 Million	+194.47%
2018-12-31	Skr34.80 Million ≈ $3.74 Million	-35.90%
2017-12-31	Skr54.29 Million ≈ $5.84 Million	+30.88%
2016-12-31	Skr41.48 Million ≈ $4.46 Million	-30.27%
2015-12-31	Skr59.48 Million ≈ $6.40 Million	+797.42%
2014-12-31	Skr6.63 Million ≈ $713.28K	-69.37%
2013-12-31	Skr21.64 Million ≈ $2.33 Million	+62.83%
2012-12-31	Skr13.29 Million ≈ $1.43 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Organoclick AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 30558703600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr1.10 Million	7.25%
Other Components	Skr327.65 Million	2158.72%
Total Equity	Skr15.18 Million	100.00%

Organoclick AB Competitors by Market Cap

The table below lists competitors of Organoclick AB ranked by their market capitalization.

Company	Market Cap
The Agency Group Australia Ltd AU:AU1	$6.84 Million
Seafarms Group Ltd AU:SFG	$6.84 Million
Apptech Corp NASDAQ:APCX	$6.85 Million
Stelar Metals Ltd AU:SLB	$6.85 Million
REFINED METALS CORP. O.N. F:CWA0	$6.84 Million
Paulic Meunerie Sa PA:ALPAU	$6.83 Million
BigBen Interactive PA:BIG	$6.83 Million
Constellation Resources Ltd AU:CR1	$6.83 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Organoclick AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 28,976,000 to 15,178,000, a change of -13,798,000 (-47.6%).
Net loss of 36,372,000 reduced equity.
Share repurchases of 20,182,000 reduced equity.
New share issuances of 20,182,000 increased equity.
Other comprehensive income decreased equity by 142,999.
Other factors increased equity by 22,716,999.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-36.37 Million	-239.64%
Share Repurchases	Skr20.18 Million	-132.97%
Share Issuances	Skr20.18 Million	+132.97%
Other Comprehensive Income	Skr-143.00K	-0.94%
Other Changes	Skr22.72 Million	+149.67%
Total Change	Skr-	-47.62%

Book Value vs Market Value Analysis

This analysis compares Organoclick AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.88x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 2.01x to 3.88x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Skr0.29	Skr0.58	x
2013-12-31	Skr0.11	Skr0.58	x
2014-12-31	Skr-0.18	Skr0.58	x
2015-12-31	Skr0.65	Skr0.58	x
2016-12-31	Skr0.32	Skr0.58	x
2017-12-31	Skr0.46	Skr0.58	x
2018-12-31	Skr0.16	Skr0.58	x
2019-12-31	Skr0.97	Skr0.58	x
2020-12-31	Skr0.58	Skr0.58	x
2021-12-31	Skr1.05	Skr0.58	x
2022-12-31	Skr0.60	Skr0.58	x
2023-12-31	Skr0.46	Skr0.58	x
2024-12-31	Skr0.30	Skr0.58	x
2025-12-31	Skr0.15	Skr0.58	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Organoclick AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -239.64%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -34.25%
• Asset Turnover: 0.79x
• Equity Multiplier: 8.91x
Recent ROE (-239.64%) is below the historical average (-83.42%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	-54.07%	-741.39%	0.05x	1.37x	Skr-9.46 Million
2013	-177.95%	-133.94%	0.26x	5.20x	Skr-10.97 Million
2014	0.00%	-74.69%	0.85x	0.00x	Skr-14.40 Million
2015	-47.14%	-65.52%	0.37x	1.94x	Skr-24.19 Million
2016	-137.53%	-77.02%	0.46x	3.85x	Skr-32.09 Million
2017	-85.25%	-36.92%	0.73x	3.15x	Skr-30.81 Million
2018	-167.42%	-25.82%	0.89x	7.29x	Skr-21.45 Million
2019	-23.62%	-21.47%	0.49x	2.23x	Skr-26.13 Million
2020	-36.10%	-20.24%	0.63x	2.83x	Skr-24.93 Million
2021	-30.93%	-28.20%	0.58x	1.88x	Skr-41.07 Million
2022	-70.81%	-36.18%	0.71x	2.77x	Skr-47.50 Million
2023	-35.38%	-10.81%	0.97x	3.38x	Skr-20.23 Million
2024	-62.02%	-14.12%	1.00x	4.38x	Skr-20.87 Million
2025	-239.64%	-34.25%	0.79x	8.91x	Skr-37.89 Million

Industry Comparison

This section compares Organoclick AB's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

Industry: Specialty Chemicals
Average net assets among peers: $183,260,440
Average return on equity (ROE) among peers: -17.05%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Organoclick AB (ORGC)	Skr18.77 Million	-54.07%	6.87x	$6.84 Million
Svenska Aerogel Holding AB (publ) (AERO)	$33.76 Million	-101.44%	0.34x	$4.41 Million
Arla Plast AB (ARPL)	$341.78 Million	24.91%	0.74x	$85.80 Million
aXichem AB (AXIC-A)	$40.33 Million	-42.80%	0.52x	$16.73 Million
HEXPOL AB (publ) (HPOL-B)	$881.00 Million	18.39%	1.27x	$3.06 Billion
I-Tech (ITECH)	$136.24 Million	14.83%	0.12x	$85.73 Million
Nexam Chemical Holding AB (NEXAM)	$187.51 Million	-3.07%	0.50x	$36.40 Million
Photocat AS (PCAT)	$3.40 Million	0.00%	1.08x	$3.29 Million
Polygiene AB (POLYG)	$3.92 Million	36.19%	1.49x	$19.18 Million
Triboron International AB (publ) (TRIBO-B)	$21.41 Million	-100.43%	0.09x	$7.17 Million

About Organoclick AB

ST:ORGC Sweden Specialty Chemicals

Market Cap

$6.84 Million

Skr63.58 Million SEK

Market Cap Rank

#27939 Global

#619 in Sweden

Share Price

Skr0.58

Change (1 day)

+43.78%

52-Week Range

Skr0.36 - Skr2.00

All Time High

Skr14.00